Stockreport

Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Alumis Inc.  (ALMS) 
PDF SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a [Read more]